Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05398211
Other study ID # REK 457017
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 15, 2022
Est. completion date May 31, 2023

Study information

Verified date April 2024
Source Oslo University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to assess feasibility and potential effectiveness of two different music interventions for managing delirium symptoms in acute geriatric patients.


Description:

Delirium is a neuropsychiatric syndrome characterized by an acute alteration in attention, awareness, arousal and cognition, precipitated by an acute illness, intoxication, trauma or surgery. It is highly prevalent in older, frail and acutely hospitalized patients, and associated with poor outcomes, with few effective treatment alternatives. Non-pharmacological interventions and music show promising effects. This study protocol aims to determine whether music interventions (MIs) delivered by a credentialed music therapist, are feasible and effective for regulating delirium symptoms in acute geriatric patients and whether the standardized delirium tools are sensitive to detect observable responses. Primary, feasibility outcomes are evaluating recruitment rate, treatment fidelity and adherence, as well as feasibility and accuracy in data collection procedures. Main effect-outcome is delirium severity, but delirium duration, cognitive status, length of hospital stay, and medication use will also be recorded. The randomised repeated measures controlled trial design will record the participant responses before and after exposure to MIs (+/- 2 hours). Participants with delirium from an acute geriatric ward will be randomized to either live or recorded MI. Each intervention will be delivered to n=30 participants (n=60 in total), for 30 minutes, over three consecutive days. Ethical approval has been obtained from Regional Ethics Committee South East Norway.


Recruitment information / eligibility

Status Completed
Enrollment 26
Est. completion date May 31, 2023
Est. primary completion date May 31, 2023
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria: - Aged = 65 and with delirium or possible delirium at admission or detected within the last 72 hours, and still present. - Appropriate informed consent is obtained. - Participants will not be excluded if they are under long term care and have comorbidities such as dementia or mild cognitive impairment. - Patients will not be excluded if they have Covid-19. Exclusion Criteria: - Patients who were previously enrolled, and were readmitted during the study period will not be re-included. - The patients with severe hearing impairments, severe psychiatric conditions, and/or severe alcohol/substance addiction where that is the main reason for admission will be excluded. - The patients whose assessed musical preferences involve orchestral or other kinds of music which cannot be performed live by voice and a guitar.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Preferred Recorded Music (PRM)
Preferred Recorded Music (PRM) involves a credentialed music therapist in planning and administering, which qualifies it as music therapy, which is defined as a professional use of music and its elements to improve physical, social, communicative, emotional, intellectual, and spiritual health, optimize quality of life and wellbeing(Aigen, 2013; Bruscia, 2014). PRM intervention will be delivered for 30 minutes, once per day at the same time of the day, for three consecutive days. The intervention will consist of the previously assessed preferred songs/musical pieces. During the PRM intervention the MT will start/stop the music and otherwise not engage with the participants during the listening session.
Preferred Live Music (PLM)
Preferred Live Music (PLM) involves a credentialed music therapist in planning and administering which qualifies it as music therapy, which is defined as professional use of music and its elements to improve physical, social, communicative, emotional, intellectual and spiritual health, optimize quality of life and wellbeing (Aigen, 2013; Bruscia, 2014).PRM intervention will be delivered for 30 minutes, once per day at the same time of the day, for three consecutive days. The intervention will consist of the previously assessed preferred songs/musical pieces. The MT will be more actively engaged in a musical interaction with the participants in the PLM interventions.

Locations

Country Name City State
Norway Oslo University Hospital Oslo

Sponsors (3)

Lead Sponsor Collaborator
Oslo University Hospital Norwegian Academy of Music, University of Melbourne

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Recruitment rate How many participants were recruited and randomized per month on average from those eligible, calculated by dividing the total number of the participants recruited by the total number of months that the trial recruited for. Up to 52 weeks
Primary Retention and attrition rates Retention is defined as trial completion on study intervention, and will be calculated by dividing the number of participants completing the study by the total number of participants recruited. Attrition rates will be estimated by the percentage of participants that withdrew from the study, and calculated by dividing the number of the participants who withdrew by the total number recruited. Up to 52 weeks
Primary Adherence and deviations rates Adherence to the study protocol is defined as compliance with the described study protocol, and protocol deviations as any change or divergence from the study protocol for each participant. Adherence rate will be estimated by calculating the percentage of the music sessions (interventions) actually completed from those described in the protocol (by dividing the number of completed sessions by the number of planned sessions), and deviation rates will be measured by counting the deviations per participant during their participation in the study. Up to 52 weeks
Primary Treatment fidelity rating and internal and external validity of the study The level of treatment fidelity will be determined using NIH Behavioral Change Consortium questionnaire which assesses 5 mutually exclusive categories: study design, training, delivery, receipt, and enactment. The tool lists 25 fidelity attributes that should be rated dichotomously as:" Present", "Absent but should be present", or "Not applicable". Up to 52 weeks
Secondary Delirium severity Delirium severity as assessed by Observational Scale of Level of Arousal (OSLA), Richmond Agitation Sedation Scale (RASS). Up to 7 days
Secondary Cognitive status Pre-post interventions changes in attention, orientation and short-term memory, assessed by backwards tests and digit span tests, recall tasks and orientation questions from Memorial Delirium Assessment Scale-MDAS) Up to 7 days.
Secondary Duration of delirium during hospital stay As diagnosed according to Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) criteria Up to 3 weeks.
Secondary Use of "rescue medication" during hospital stay The total number of psycho-pharmacological medications per patients will be registered. Up to 3 weeks.
Secondary Length of hospital stay The total number of days from admittance to the Acute Geriatric Department to discharge from hospital. Up to 3 weeks.
See also
  Status Clinical Trial Phase
Completed NCT05690672 - Screening for Delirium in Older Inpatients N/A
Completed NCT04656379 - The Incidence and Risk Factors of Postoperative Delirium
Recruiting NCT04187807 - Efficacy of the Administration of Melatonin 5mg in the Prevention of Delirium in Older Adults Hospitalized in the Emergency Department N/A
Active, not recruiting NCT04654962 - Use of Anesthetic Block for the Prevention of in Hospital Delirium in Patients of the Orthogeriatric Clinical Care Center of the HUFSFB and HUSJI From 2019 - 2020
Completed NCT03485183 - The Effect of White and Pink Noise on Hospitalized Older Adults N/A
Recruiting NCT05815017 - YOOMI: Effect of Gamified Physical Therapy Exercise Software on Inpatient Mobility N/A
Recruiting NCT05694091 - Correlation of Perioperative Brain Metabolites With Postoperative Delirium in Elderly Oral Craniomaxillofacial Surgery Patients
Completed NCT06382961 - Postoperative Dexmedetomidine in Prevention of Postoperative Delirium N/A
Recruiting NCT06100029 - The Effect of Lavender Essential Oil for Delirium in Elderly Intensive Care Unit Patients: Study Protocol N/A
Not yet recruiting NCT06111300 - Dexmedetomidine Effect on Delirium of Elderly Patients Phase 4
Recruiting NCT05391334 - Early Fall Risk Detection and Fall Prevention Among Inpatients With Delirium
Completed NCT06168773 - Combination of Haloperidol and Magnesium for Delirium Prevention in Critically Ill Elderly Phase 2/Phase 3
Recruiting NCT05280860 - Effect of Bilateral RSB on Postoperative Delirium in Elderly Patients Undergoing Laparoendoscopic Single-site Surgery N/A
Recruiting NCT05857462 - The Impact of Integrated Preoperative Fascia Iliaca Compartment Block in Elderly Hip Fracture N/A
Recruiting NCT04404959 - Perioperative Pain and Delirium in Geriatric Patients With Hip Fracture N/A
Not yet recruiting NCT05819723 - Erector Spinae Block and Incidence of Postoperative Delirium After Hip Fracture Surgeries N/A
Recruiting NCT04393272 - Digital Intelligent Assistant for Nursing Application
Recruiting NCT05158998 - Impact of Propofol Versus Sevoflurane on Incidence of Postoperative Delirium in Elderly Patients After Spine Surgery Phase 4
Not yet recruiting NCT06326372 - The Effect of Intraoperative Hyperoxemia on Postoperative Delirium in Geriatric Patients
Completed NCT03175276 - Informant Questionaire on Cognitive Decline in the Elderly (IQCODE) and Delirium in Geriatric Patients